RAS P21 蛋白激活剂 3 通过抑制 HCK 介导的 STAT4 磷酸化作用,精准调控 I 型免疫应答。
RAS P21 Protein Activator 3 finetunes Type I immunity by limiting HCK-mediated STAT4 phosphorylation
Song Jiayu, Liu Xiaoyu, Sun Jie, Cheng Xi, He Chuan, Zhong Yunhong, Zhang Jinfang, Zhang Junjie, Xiong Hui, Wu Bing
Journal:Nature Communications
IF:18.1
DOI:10.1038/s41467-026-76201-3
PMID:42686775
Published:2026-08-05
research field:分子生物学细胞生物学心血管研究肺动脉高压信号转导分子药理学生物化学
Abstract
Type I immunity, mediated by IFN-γ, is essential for combating intracellular pathogens but also drives inflammatory diseases. How the immune system balances protective type I responses with pathological inflammation is elusive. While the IL-12-STAT4 pathway that promotes IFN-γ production is well-established, the intrinsic negative regulators remain unclear. We establish that RASA3 serves as a permissive checkpoint for type I immune responses. T cell-specific ablation of RASA3 amplified Th1/Tc1 immunity and IFN-γ expression, enhancing the clearance of Listeria monocytogenes but exacerbating allergic contact dermatitis. We further identify the hematopoietic cell kinase (HCK) as a direct kinase for STAT4, which binds to and phosphorylates it at the Tyr693 residue to elicit IFN-γ production. Mechanistically, RASA3 represses the translation of HCK via constraining ribosomal protein RPL36A expression. Additionally, the RASA3-HCK axis is conserved in human Th1 cells. Thus, we define a critical role of the RASA3-HCK-STAT4 axis in fine-tuning type I immunity and offer promising targets for intervening in Th1/Tc1-driven pathologies.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


